APA (7th ed.) Citation

Tard, C., Sacconi, S., Taouagh, N., Bouhour, F., Michaud, M., Beltran, S., . . . Spinazzi, M. (2026). Real‐Life Effectiveness After Switching to Avalglucosidase Alfa in Late‐Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study. European Journal of Neurology, 33(7), 1. https://doi.org/10.1111/ene.70680

Chicago Style (17th ed.) Citation

Tard, Céline, et al. "Real‐Life Effectiveness After Switching to Avalglucosidase Alfa in Late‐Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study." European Journal of Neurology 33, no. 7 (2026): 1. https://doi.org/10.1111/ene.70680.

MLA (9th ed.) Citation

Tard, Céline, et al. "Real‐Life Effectiveness After Switching to Avalglucosidase Alfa in Late‐Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study." European Journal of Neurology, vol. 33, no. 7, 2026, p. 1, https://doi.org/10.1111/ene.70680.